Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

DPCP alone is more effective and safer for treating chronic extensive alopecia areata than combining it with anthralin.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Topical 5-Fluorouracil can rarely cause nerve damage, especially in people with a certain genetic deficiency.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Tanshinone IIA helps protect skin tissue from low oxygen damage by boosting certain cell markers.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Tofacitinib might be used to treat hair loss.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.